Daily Derm Times: August 27, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Journal Digest: August 27, 2025

This review of the latest dermatologic studies focuses on chronic spontaneous urticaria with new research on the transition from omalizumab to dupilumab, metabolic syndrome in urticaria patients, current pediatric CSU guidelines, and more.

How to Individualize Biologic Therapy in Severe Prurigo Nodularis

Explore innovative biologic treatments for prurigo nodularis, enhancing patient quality of life and breaking the itch-scratch cycle effectively.

Mallia Aesthetics Completes Regulatory Milestones for Novel sCD83-Based Hair Growth Technology

Key regulatory milestones for MAL-838, a novel sCD83-based, hormone-free hair growth ingredient, are paving the way for the market launch of a microbiome-friendly 8T3 product line.

Dermatology Times August 2025 Print Recap

Learn more about the in-depth topics covered in the August 2025 print issue of Dermatology Times.

Pediatric Pearls: Insights from Lisa Swanson, MD, FAAD, at DERM 2025

Lisa Swanson, MD, FAAD, shares innovative insights on pediatric dermatology, emphasizing effective treatments and communication strategies for young patients at DERM 2025.

A Podcast by PAs for PAs: SkinSync Elevates Dermatology Voices

Members of Elevate-Derm Alliance and the SkinSync podcast discuss the inspiration behind the podcast and how it best serves dermatology clinicians.

Derm Dispatch: Exploring GLP-1s’ Role in Inflammation and Skin Disease

GLP-1 receptor agonists may indirectly affect dermatologic outcomes by targeting inflammation and metabolic comorbidities.